[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355799-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355799-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","new-frontiers-in-contrast-enhanced-ultrasound-for-cancer-imaging-review","New Frontiers in Contrast-Enhanced Ultrasound for Cancer Imaging - Review","","Nanobubbles (NBs) are increasingly recognized as the next generation of ultrasound contrast agents that can advance cancer imaging and therapy. Compared with clinically used microbubbles restricted to the vasculature, NBs (200–500 nm) may target perivascular and possibly extravascular compartments. Engineered polymeric, lipid, or hybrid shells can tune stability, extend circulation, and enable receptor-directed binding with functional ligands. Preclinical studies report longer imaging windows, higher sensitivity, improved tumor-to-background contrast, and multimodal compatibility, while clinical translation still requires overcoming acoustic optimization, manufacturing reproducibility, and comprehensive safety evaluation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/new-frontiers-in-contrast-enhanced-ultrasound-for-cancer-imaging-review/355799/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/new-frontiers-in-contrast-enhanced-ultrasound-for-cancer-imaging-review/355799.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are nanobubbles (NBs) and why are they important for cancer imaging?","Question",{"text":63,"@type":64},"Nanobubbles are ultrasound contrast agents viewed as the next generation for cancer imaging and therapy. Their size and engineered shells may enable targeting beyond what microbubbles can reach.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do nanobubbles differ from clinically used microbubbles (MBs)?",{"text":68,"@type":64},"Clinically used microbubbles are limited mainly to the vasculature due to their 1–10 μm size and transient enhancement. Nanobubbles with diameters around 200–500 nm can potentially access perivascular and possibly extravascular compartments.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges must be addressed before nanobubbles can be clinically translated?",{"text":72,"@type":64},"Key barriers include acoustic optimization and standardization, formulation and manufacturing reproducibility, and comprehensive safety characterization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355799,1790516084,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":33,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","This article is licensed under CC-BY 4.0   \n[www.acsnano.org](www.acsnano.org)  Review   \nNew Frontiers in Contrast-Enhanced Ultrasound for Cancer Imaging  \nFelipe Matias Berg, Michaela Briana Cooley, Theresa Kosmides, Laura E. Chen, Ronaldo Hueb Baroni,* and Agata A. Exner*  \n Cite This: ACS Nano 2026, 20, 14327−14350  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Nanobubbles (NBs) are increasingly recognized asthe next generation of ultrasound contrast agents that can provide alternate avenues for the advancement of cancer imaging and therapy. Compared to currently clinically viable microbubbles that are limited to the vasculature because of their size, nanobubbles with diameters ranging from 200 to 500 nm can potentially target the perivascular and possibly extravascular compartments. Their polymeric, lipid, or hybrid shells can be engineered to tune stability, increase circulation time, and support surface functionalization with ligands to facilitate receptor-directed binding. Preclinical studies show that NBs can extend ultrasound imaging windows, improve sensitivity, and increase tumor-to-background contrast across  \ndifferent types of cancers. NBs can also be formulated with secondary reporters that allow their combination with other imaging modalities, such as optical (photoacoustic and fluorescence) and magnetic resonance imaging. However, several challenges need tobe overcome to allow the clinical translation of NBs, such as acoustic optimization and standardization, formulation and manufacturing reproducibility, and comprehensive safety characterization. Addressing these barriers will be essential to establishing NBs as clinically viable agents. Here, we summarize recent advances in NB design and functionalization, review key preclinical oncology applications, and discuss translational priorities to support their integration into precision oncology clinical workflows. KEYWORDS: nanobubbles, contrast media, ultrasonography, neoplasms, molecular imaging, nanoparticles, interventional radiology, microbubbles, early diagnosis, multimodal imaging  \n1. INTRODUCTION  \nCancer remains one of the most important challenges in global healthcare, even with major advances in diagnosis and treatment over the past few decades. An estimated 10 million cancerrelated deaths occur each year, leading to not only stress over the healthcare system but also an extraordinary economic burden as well. 1−4 Projections based on macroeconomic models indicate that the costs to the economy as a result of the advent of cancer between the years 2020 and 2050 are set to exceed a whopping US $25 trillion.5 The effects in terms of both expenditure and health disparities do not fall evenly across regions, while early diagnosis and immediate treatment are core to the successful reduction of mortalities due to cancer and the overall financial costs, about 70% of total deaths due to cancer are in areas where proper screening is rarely implemented, even in the presence of valid screening methods.6 In addition, while there can be early diagnosis of the diseases, curative interventions in these conditions entail highly resource-consuming and risky surgeries, which in turn are applicable only in selected locations.7,8 Together, these gaps highlight the need for more accessible diagnostic and therapeutic platforms for cancer.  \nUltrasound is uniquely positioned to meet this need because of its availability worldwide, comparatively low-cost, and capability of point-of-care real-time imaging.9, 10 Yet in oncology,  \nconventional ultrasound underperforms in terms of lesion characterization and comprehensive disease assessment 􀀁 limitations that are driven in large part by the contrast paradigm rather than the imaging platform itself.11 Contrast-enhanced ultrasound (CEUS), which combines intravenous administration of gas-filled microbub","cbCaig7h6WpeqJDA","https://ap.wps.com/l/cbCaig7h6WpeqJDA","pdf",11190875,24,"English","# Abstract\n# 1. Introduction\n## Contrast-enhanced ultrasound in oncology\n## Limitations of microbubble-based CEUS\n# Figure 1 - Research and intellectual property trajectory","[{\"question\":\"What are nanobubbles (NBs) and why are they important for cancer imaging?\",\"answer\":\"Nanobubbles are ultrasound contrast agents viewed as the next generation for cancer imaging and therapy. Their size and engineered shells may enable targeting beyond what microbubbles can reach.\"},{\"question\":\"How do nanobubbles differ from clinically used microbubbles (MBs)?\",\"answer\":\"Clinically used microbubbles are limited mainly to the vasculature due to their 1–10 μm size and transient enhancement. Nanobubbles with diameters around 200–500 nm can potentially access perivascular and possibly extravascular compartments.\"},{\"question\":\"What challenges must be addressed before nanobubbles can be clinically translated?\",\"answer\":\"Key barriers include acoustic optimization and standardization, formulation and manufacturing reproducibility, and comprehensive safety characterization.\"}]","New Frontiers in Contrast-Enhanced Ultrasound for Cancer Imaging - Review | PDF",1790121026,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e6a9fb65ba184e1c0d221f462c9370c.webp",983,1296,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e50af364b44b467105737f6dfdc2d41.webp",982,1295,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eca905621a77de26b3da0b1e4519034.webp",981,1293,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4be3a6e9f950dcc0fbc4e4a639a1e54f.webp",980,1292]